Cargando…
Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
Allogeneic stem cell transplantation (allo-SCT) is a curable method for the treatment of hematological malignancies. In the past two decades, the establishment of haploidentical transplant modalities make “everyone has a donor” become a reality. However, graft-versus-host disease (GVHD) and relapse...
Autores principales: | Chang, Ying-Jun, Zhao, Xiang-Yu, Huang, Xiao-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308132/ https://www.ncbi.nlm.nih.gov/pubmed/30619371 http://dx.doi.org/10.3389/fimmu.2018.03041 |
Ejemplares similares
-
IL-Y Aggravates Murine Chronic Graft-Versus-Host Disease by Enhancing T and B Cell Responses
por: Wan, Li, et al.
Publicado: (2020) -
Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect
por: Huang, Ying, et al.
Publicado: (2022) -
LPS(low)-Macrophages Alleviate the Outcome of Graft-Versus-Host Disease Without Aggravating Lymphoma Growth in Mice
por: Jeljeli, Mohamed, et al.
Publicado: (2021) -
Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
por: Dekker, Linde, et al.
Publicado: (2022) -
γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation
por: Wu, Ning, et al.
Publicado: (2021)